DSS, Inc. Withdraws Registration Statement

DSS (NYSE American: DSS) announced it has withdrawn its previously filed Form S-1 registration statement with the SEC.

Rhea-AI Summary

DSS (NYSE American: DSS) announced it has withdrawn its previously filed Form S-1 registration statement with the SEC. Management and the Board determined current market conditions and deal terms would not reflect the value DSS believes it is building for shareholders.

The company states the withdrawal does not change its business outlook, operating strategy, or confidence in its assets and subsidiaries. DSS will continue evaluating financing alternatives and capital markets options, while advancing strategic initiatives including the previously announced merger involving Impact Biomedical.

Positive

• Offering withdrawn because terms seen as not reflecting perceived shareholder value
• Company states no change in business outlook or operating strategy
• Management reiterates confidence in value of assets and subsidiaries
• Flexibility maintained to access capital markets at more favorable terms
• Company continues to pursue strategic initiatives, including Impact Biomedical merger

Negative

• Planned securities offering on Form S-1 will not proceed as previously filed
• Uncertain timing for future capital raises amid current market conditions

Argus Jun 9 session

+19.55% close to close Open Argus

Details

News Market Reaction – DSS

In the Jun 9 session, DSS gained 19.55%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +19.6% in the session following this news. A strong positive reaction aligns with D...

Analysis

The stock surged +19.6% in the session following this news. A strong positive reaction aligns with DSS stepping back from an equity offering after a series of dilutive capital raises and going-concern disclosures. Investors may have viewed withdrawing the Form S-1 as reducing near-term issuance pressure. However, filings show larger net losses, substantial debt and prior offerings that weighed on the stock, so any enthusiasm around reduced dilution must be weighed against ongoing financing needs and balance-sheet risks highlighted in recent 10-Q and 10-K reports.

Historical Context

5 past events · Latest: May 08

5 events

1. May 08

   Going concern notice

   24h Move

   -0.9%

   10-K audit opinion included a going concern paragraph for 2025 results.

2. Apr 15

   Shareholder update

   24h Move

   +0.2%

   Letter detailed 2025 cost cuts, revenue growth and strategic portfolio actions.

3. Feb 05

   Offering closing

   24h Move

   -5.3%

   Closed $1.0M underwritten equity offering for general corporate purposes.

4. Feb 04

   Offering pricing

   24h Move

   -32.4%

   Priced 900,000-share underwritten offering at $1.00 per share with over-allotment.

5. Feb 03

   Offering launch

   24h Move

   -32.4%

   Announced proposed public stock offering for working capital and corporate uses.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

registration statement, form s-1, u.s. securities and exchange commission

3 terms

registration statement regulatory

"it has withdrawn its previously filed Registration Statement on Form S-1"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

form s-1 regulatory

"its previously filed Registration Statement on Form S-1 with the U.S. Securities"

A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.

u.s. securities and exchange commission regulatory

"on Form S-1 with the U.S. Securities and Exchange Commission."

The U.S. Securities and Exchange Commission is a government agency responsible for overseeing the stock market and protecting investors. It sets rules to ensure that companies share truthful information and that trading is fair, helping to maintain trust in the financial system. This oversight is important because it helps prevent fraud and ensures that investors can make informed decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) today announced that it has withdrawn its previously filed Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission. After careful review of current market conditions and deal terms, management and the Board of Directors concluded that proceeding with the offering at this time would not reflect the value DSS believes it is building for shareholders.

DSS remains well-positioned to access the capital markets and is committed to doing so at a time and on terms that are most conducive to the Company's strategic plan and that appropriately reflect the value of its business. The Company will continue to evaluate financing alternatives and capital markets opportunities as conditions develop.

"We are focused on executing our business plan and creating long-term value for our shareholders," said Jason Grady, Chief Executive Officer of DSS, Inc. "Accessing capital on the right terms, at the right time, is an important part of that discipline. We are confident in the direction of the Company and will pursue opportunities that align with where we are headed."

The withdrawal does not reflect any change in the Company’s business outlook, operating strategy, or confidence in the value of its assets and subsidiaries. 

“DSS continues to believe there are significant opportunities across our businesses,” Grady added. "We remain focused on advancing several strategic initiatives, including the previously announced merger involving Impact Biomedical, which we believe has the potential to create meaningful long-term value for shareholders."

DSS continues to evaluate opportunities to unlock value across its portfolio while maintaining financial and strategic flexibility.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DSS, Inc.

DSS, Inc. (NYSE American: DSS) is a multinational company operating across multiple business lines including product packaging, biotechnology, commercial lending, and securities and investment management. The Company operates a business model based on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings. For more information, visit www.dssworld.com.

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve known and unknown risks and uncertainties that may cause DSS's actual results to differ materially from those expressed or implied by such forward-looking statements. DSS undertakes no obligation to publicly update or revise any forward-looking statements.

Investor Contact:

DSS, Inc.
Investor Relations
ir@dssworld.com
+1 (585) 565-2422

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DSS (NYSE American: DSS) announce about its Form S-1 registration on June 9, 2026?

DSS announced it has withdrawn its previously filed Form S-1 registration statement with the SEC. According to DSS, the decision follows review of current market conditions and deal terms, which were viewed as not reflecting the value being built for shareholders.

Why did DSS withdraw its securities offering and registration statement in June 2026?

DSS withdrew the offering after management and the Board reviewed market conditions and deal terms. According to DSS, they concluded proceeding now would not reflect the value they believe they are building for shareholders and prefer to access capital on more suitable terms.

Does DSS’s withdrawal of the Form S-1 affect its business outlook or strategy?

DSS states the withdrawal does not change its business outlook, operating strategy, or confidence in asset value. According to DSS, the company remains focused on executing its business plan and creating long-term shareholder value while monitoring capital markets opportunities.

How will the DSS registration withdrawal impact future capital raising plans for DSS stock (DSS)?

DSS indicates it remains well-positioned to access capital markets despite withdrawing the Form S-1. According to DSS, it will continue evaluating financing alternatives and intends to raise capital when timing and terms better align with its strategic plan and perceived business value.

What role does the Impact Biomedical merger play after DSS’s withdrawn offering?

DSS highlights the previously announced merger involving Impact Biomedical as a key strategic initiative. According to DSS, it believes this transaction has potential to create meaningful long-term shareholder value and remains focused on advancing it alongside other portfolio value-unlocking efforts.

Is DSS still confident in its assets and subsidiaries after canceling the planned offering?

DSS affirms ongoing confidence in the value of its assets and subsidiaries despite withdrawing the offering. According to DSS, it continues to see significant opportunities across its businesses and aims to unlock value while maintaining financial and strategic flexibility.